JPMorgan Chase & Co’s Prime Medicine PRME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $81.6K | Sell |
33,035
-2,628
| -7% | -$6.49K | ﹤0.01% | 4880 |
|
|
2025
Q1 | $71K | Buy |
35,663
+23
| +0.1% | +$46 | ﹤0.01% | 4900 |
|
|
2024
Q4 | $104K | Sell |
35,640
-1,742
| -5% | -$5.09K | ﹤0.01% | 4767 |
|
|
2024
Q3 | $145K | Sell |
37,382
-805
| -2% | -$3.12K | ﹤0.01% | 4586 |
|
|
2024
Q2 | $196K | Sell |
38,187
-3,894
| -9% | -$20K | ﹤0.01% | 4284 |
|
|
2024
Q1 | $295K | Sell |
42,081
-3,438
| -8% | -$24.1K | ﹤0.01% | 4239 |
|
|
2023
Q4 | $403K | Buy |
45,519
+18,505
| +69% | +$164K | ﹤0.01% | 4025 |
|
|
2023
Q3 | $258K | Sell |
27,014
-3,658
| -12% | -$34.9K | ﹤0.01% | 4088 |
|
|
2023
Q2 | $449K | Buy |
30,672
+17,775
| +138% | +$260K | ﹤0.01% | 3820 |
|
|
2023
Q1 | $159K | Buy |
12,897
+3,023
| +31% | +$37.3K | ﹤0.01% | 4439 |
|
|
2022
Q4 | $184K | Buy |
+9,874
| New | +$184K | ﹤0.01% | 4245 |
|